Stay updated with breaking news from Vuja De Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases...
Natick, MA, and Hoboken, NJ (PRWEB) April 06, 2022 -- HebeCell Corporation (“HebeCell”) and Vuja De Sciences, Inc. (“Vuja De”) have announced today their
Natick, MA, and Hoboken, NJ, and Montreal, Quebec (PRWEB) January 05, 2022 -- Cyclenium Pharma, Inc. (“Cyclenium”), an emerging pharmaceutical company
Natick, MA and Hoboken, NJ (PRWEB) December 21, 2021 -- Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to discovering therapies that prevent